# Resonant Therapeutics, Inc. — Form D

Resonant Therapeutics, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-28. The offering totals $4.1M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-10-28
- Form: D
- Accession: 0001656695-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.1M
- Amount sold: $2.5M
- Remaining: $1.5M
- Investors: 16
- Date of first sale: 2021-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-418881

## Issuer

- Name: Resonant Therapeutics, Inc.
- CIK: 0001656695
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2450 Holcombe Blvd., Houston, TX, 77021
- Phone: 925.389.8539

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Dan K Watkins | Director | Houston, TX |
| John K Westwick | Director | Houston, TX |
| John K Westwick | Executive Officer | Houston, TX |
| Dan K Watkins | Executive Officer | Houston, TX |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-08-09](https://search.stillhousedata.com/formd/0001656695-17-000001) | D | $2.6M | $1.4M |
| [2015-10-26](https://search.stillhousedata.com/formd/0001656695-15-000001) | D | $2.0M | $1.2M |

## More

- [CIK 1656695 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1656695&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001656695-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.